Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Fotis Vlastos"'
Autor:
Vasiliki Metaxa-Mariatou, Jubrail Dahabreh, Angela Apessos, Aggeliki Rapti, Vasileios Karavasilis, N Papageorgiou, Charalampos Zoublios, Mina Gaga, P. Zarogoulidis, Dimitrios Veldekis, George Nasioulas, Gerasimos Aravantinos, Stylianos Kakolyris, Konstantinos Zarogoulidis, Dimitrios Kasarakis, Napoleon Karagiannidis, Fotis Vlastos, Angeliki Tsirigoti, Eirini Papadopoulou, Konstantinos Agiannitopoulos, Nikolaos Tsoulos
Publikováno v:
Oncology Letters. 10:2176-2184
It has been reported that certain patients with non-small-cell lung cancer (NSCLC) that harbor activating somatic mutations within the tyrosine kinase domain of the epidermal growth factor receptor (EGFR) gene may be effectively treated using targete
Autor:
Nikolaos Koulouris, Jean Michel Vignaud, Nadine Martinet, Fotis Vlastos, Georgios Hillas, Nektarios Anagnostopoulos
Publikováno v:
Journal of Cancer Therapy. :24-28
Background: Lung Adenocarcinoma (ADC) has been recently associated with distinct molecular changes, leading to the development of molecular-based targeted therapy. The Nancy’s Centre of Biological Resources (“Centre des Ressources Biologiques”,
Autor:
Stéphanie Lacomme, Fotis Vlastos, Ekkehard Vollmer, Josune Guzman-Costabel, Georgios Hillas, Françoise Galateau-Sallé, Nadine Martinet, Jean Michel Vignaud, Philippe Vidal
Publikováno v:
Journal of Thoracic Oncology. 4:1259-1263
Introduction:We report a survey of mesothelioma survival rates with insights into the survival benefit because of pemetrexed. We also studied a potential link between specific single nucleotide polymorphisms of transcobalamin II (TCII) gene and susce
Publikováno v:
Journal of Cellular and Molecular Medicine
Lung carcinogenesis is a complex process requiring the acquisition of genetic mutations that confer the malignant phenotype as well as epigenetic alterations that may be both manipulated in the course of therapy. Aberrant gene function and transcript
Autor:
Rodoula Trigidou, George Kaltsakas, Charoula Eleni Giannakopoulou, Irene Papadopoulou, Nikolaos Koulouris, Fotis Vlastos, Grigorios Stratakos
Publikováno v:
11.1 Lung Cancer.
Interleukin-18 (IL-18) is a multifunctional cytokine that augments IFN-γ production and affects tumor immune response. No study exists investigating the expression of IL-18 and IL-18 receptor (IL-18R) mRNA in lung tissue samples of NSCLC patients. T
Autor:
Eirini, Papadopoulou, Nikolaos, Tsoulos, Angeliki, Tsirigoti, Angela, Apessos, Konstantinos, Agiannitopoulos, Vasiliki, Metaxa-Mariatou, Konstantinos, Zarogoulidis, Pavlos, Zarogoulidis, Dimitrios, Kasarakis, Stylianos, Kakolyris, Jubrail, Dahabreh, Fotis, Vlastos, Charalampos, Zoublios, Aggeliki, Rapti, Niki Georgatou, Papageorgiou, Dimitrios, Veldekis, Mina, Gaga, Gerasimos, Aravantinos, Vasileios, Karavasilis, Napoleon, Karagiannidis, George, Nasioulas
Publikováno v:
Oncology Letters
It has been reported that certain patients with non-small-cell lung cancer (NSCLC) that harbor activating somatic mutations within the tyrosine kinase domain of the epidermal growth factor receptor (EGFR) gene may be effectively treated using targete
Autor:
Dimitrios Veldekis, Stylianos Loukides, Nikoletta Rovina, Fotis Vlastos, Georgios Hillas, Petros Bakakos, Charis Roussos, Manos Alhanatis, Efrossini Dima
Publikováno v:
Cytokine. 54(3)
Cytokines are key players in the biological processes of malignant tumors and special interest has been focused on cytokines exerting tumor and anti-tumor properties, such as vascular endothelial growth factor (VEGF) and Interleukin-18 (IL-18). Aim o
Autor:
Georgia Hardavella, Stéfanie Lacomme, Leonidas Vordonis, Jean Michel Vignaud, Fotis Vlastos, Nadine Martinet, Julie Zinszner, Thomas Hussenet, Stanislas du Manoir, Sofia Nikolakopoulou
Publikováno v:
Diagnostic molecular pathology : the American journal of surgical pathology, part B. 19(4)
INTRODUCTION Unselected lung cancer patients seem unable to gain in terms of survival from treatment with epidermal growth factor receptor (EGFR) inhibitors. Screening for specific molecular targets involves detection of EGFR1 mutations. The aim of o
Autor:
Dimitrios Veldekis, Ioanna Haziri, Fotis Vlastos, Georgios Hillas, Charalampos Dimitropoulos, Ioannis Ntanos, Ioanna Kostara
Publikováno v:
C40. LUNG CANCER: PATHOBIOLOGY, STAGING, AND TREATMENT.
Autor:
Fotis Vlastos, Georgios Hillas, Ioannis Ntanos, Dimitrios Veldekis, Charalampos Dimitropoulos, Ioanna Kostara, Alexandra Kopitopoulou
Publikováno v:
C40. LUNG CANCER: PATHOBIOLOGY, STAGING, AND TREATMENT.